PUBLISHER: The Business Research Company | PRODUCT CODE: 2077808
PUBLISHER: The Business Research Company | PRODUCT CODE: 2077808
Medical instrument disinfection is the process of eliminating most disease-causing microorganisms, excluding certain resistant spores, from medical devices through chemical agents or physical methods. Its primary objective is to minimize the risk of healthcare-associated infections (HAIs), protect patient health, and maintain hygiene standards in healthcare settings. Additionally, it helps ensure the longevity and proper performance of medical instruments by preventing contamination and deterioration.
The primary types of disinfectants used in medical instrument disinfection comprise alcohol-based disinfectants, chlorine-based disinfectants, phenolic disinfectants, quaternary ammonium compounds (quats), and hydrogen peroxide. Alcohol-based disinfectants refer to fast-acting antimicrobial solutions commonly used for rapid decontamination of medical instruments and surfaces in clinical environments. They are categorized by formulation type such as ready-to-use formulations, concentrated formulations, wipes, sprays, and high-level disinfectants and they are distributed through direct sales, online retail, medical supply distributors, pharmacies, and wholesale suppliers. The various applications involved are pre-procedural disinfection, post-procedural disinfection, surface disinfection, instrument sterilization, and environmental disinfection and they are utilized by end users including hospitals and clinics, biotechnology and pharmaceutical companies, dental practices, ambulatory surgical centers, and research laboratories.
Tariffs are influencing the medical instrument disinfections market by increasing the cost of imported disinfectant chemicals, sterilization equipment, and advanced medical-grade cleaning systems. This is impacting supply chains for premium hydrogen peroxide systems, quaternary ammonium compounds, and automated sterilization devices, particularly in import-dependent regions such as Asia-Pacific and Latin America. Hospitals, ambulatory surgical centers, and laboratories are experiencing the greatest effects due to their dependence on consistent and regulated infection-control supplies. However, tariffs are also encouraging local disinfectant production, regional supply chain diversification, and innovation in cost-effective sterilization technologies, ultimately strengthening healthcare self-reliance and resilience.
The medical instruments disinfections market research report is one of a series of new reports from The Business Research Company that provides medical instruments disinfections market statistics, including medical instruments disinfections industry global market size, regional shares, competitors with a medical instruments disinfections market share, detailed medical instruments disinfections market segments, market trends and opportunities, and any further data you may need to thrive in the medical instruments disinfections industry. This medical instruments disinfections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical instruments disinfections market size has grown strongly in recent years. It will grow from $3.47 billion in 2025 to $3.75 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising healthcare-associated infection cases, increasing hospital infrastructure expansion, growing awareness of infection control protocols, expansion of surgical and diagnostic procedures, stricter regulatory hygiene standards in healthcare settings.
The medical instruments disinfections market size is expected to see strong growth in the next few years. It will grow to $5.2 billion by 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising adoption of automated sterilization systems, increasing demand for sustainable disinfectant chemicals, growth in outpatient and ambulatory surgical procedures, integration of smart tracking in sterilization workflows, expansion of biotechnology-driven infection control solutions. Major trends in the forecast period include low-temperature enzymatic and chemical disinfection process optimization, automated sterilization tracking and validation systems in healthcare facilities, eco-friendly biodegradable medical disinfectant formulation development, advanced surface-compatible antimicrobial coating integration for instruments, rapid high-level disinfection technologies for reusable surgical instruments.
The increasing prevalence of healthcare-associated infections is expected to propel the growth of the medical instrument disinfection market going forward. Healthcare-associated infections refer to infections acquired by patients during the course of receiving treatment within healthcare facilities, which can negatively impact patient safety and clinical outcomes. The rising incidence of healthcare-associated infections is primarily driven by increased hospital utilization, a growing aging population, and a higher prevalence of patients with multiple comorbidities, thereby contributing to sustained market demand. Medical instrument disinfection solutions support healthcare systems by providing effective disinfection technologies that reduce the transmission of infections through contaminated medical instruments and ensure safer patient care environments. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government public health organization, and additionally in January 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, there was an approximate 4% increase in the standardized infection ratio (SIR) for surgical site infections (SSI) across all NHSN operative procedure categories compared to the previous year. Therefore, the increasing prevalence of healthcare-associated infections is propelling the growth of the medical instrument disinfection market, supported by rising infection control requirements and contributing healthcare safety initiatives.
Leading companies operating in the medical instruments disinfection market are focusing on advancing low-temperature sterilization technologies such as vaporized hydrogen peroxide (VHP) systems to enable effective reprocessing of heat-sensitive medical instruments while preserving material integrity and ensuring high-level microbial elimination. Vaporized hydrogen peroxide (VHP) sterilization is a low-temperature method that utilizes reactive hydrogen peroxide vapor to generate free radicals, which effectively destroy microorganisms on delicate medical devices without causing thermal damage. For example, in December 2024, STERIS plc, an Ireland-based provider of products and services that support patient care with an emphasis on infection prevention, received clearance from the U. S. Food and Drug Administration for its V-PRO Low Temperature Sterilizers, designed to sterilize hospital-produced 3D-printed surgical guides and anatomical models. The system is compatible with Formlabs' BioMed Amber and BioMed Clear resins, ensures dimensional stability, and is validated for use with over 43 materials, supporting safe and efficient disinfection of heat-sensitive instruments.
In November 2023, HOYA Corporation, a Japan-based technology and medical products company, acquired the remaining 49% of shares of WASSENBURG Medical B. V. for an undisclosed amount. Through this acquisition, HOYA aims to strengthen its medical instrument disinfection and flexible endoscopy capabilities by integrating WASSENBURG's automated endoscope washer-disinfectors, consumables, and related services with its PENTAX Medical division, thereby reinforcing infection control and endoscope reprocessing solutions globally. WASSENBURG Medical B. V. is a Netherlands-based company that provides medical instrument disinfection solutions, specifically for endoscopes through automated washer-disinfectors and reprocessing systems.
Major companies operating in the medical instruments disinfections market are Medline Industries LP, Evonik Industries AG, Ecolab Inc. , LANXESS AG, STERIS plc, Getinge AB, PAUL HARTMANN AG, Hu-Friedy Mfg. Co. LLC, Belimed AG, Schulke & Mayr GmbH, 3M Company, Advanced Sterilization Products Inc. , Nanosonics Limited, GAMA Healthcare Ltd, Matachana Group S. A. , SciCan Ltd. , Microgen Bioproducts Ltd, Metrex Research LLC, Tuttnauer Ltd. , BODE Chemie GmbH, Wassenburg Medical B. V. , Whiteley Corporation Pty Ltd, MMM Group GmbH
North America was the largest region in the medical instruments disinfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical instruments disinfections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the medical instruments disinfections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical instruments disinfection market consists of sales of glutaraldehyde solutions, ortho-phthalaldehyde (OPA) disinfectants, peracetic acid formulations, and iodophor disinfectants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Instruments Disinfections Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical instruments disinfections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical instruments disinfections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical instruments disinfections market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.